Clinical Trial Update: An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer

View source ↗

Summary

An observational, real-world study of the combination of pegylated liposomal doxorubicin and trabectedin in patients with recurrent partial-platinum sensitive o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)
• Trabectedin (trabectedin)

Snippet

Sponsor: Suriya Yessentayeva | Conditions: Ovarian Cancer | Status: UNKNOWN